Maine 2023-2024 Regular Session

Maine House Bill LD217

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Engrossed
5/23/23  
Enrolled
5/30/23  

Caption

An Act to Support Manufacturers Whose Products Contain Perfluoroalkyl and Polyfluoroalkyl Substances

Impact

The legislation will significantly influence state laws pertaining to environmental safety and product regulation. By requiring manufacturers to disclose information related to PFAS, the bill is positioned as a proactive measure to safeguard public health and the environment. This is particularly relevant given the well-documented concerns regarding the adverse effects of PFAS on health and the environment, propelling the state towards stricter controls on hazardous materials. Manufacturers with 25 or fewer employees are exempt from these requirements, which takes into account the challenges small businesses face in complying with stringent regulations.

Summary

LD217, also known as An Act to Support Manufacturers Whose Products Contain Perfluoroalkyl and Polyfluoroalkyl Substances, aims to regulate the use of PFAS in manufactured products sold in Maine. The bill mandates that manufacturers notify the state by January 1, 2025, if their products contain intentionally added PFAS, providing details such as the product description and quantity of PFAS used. This law seeks to increase transparency about hazardous substances in consumer products and to support environmental and public health initiatives.

Sentiment

Overall, the sentiment surrounding LD217 appears to be supportive from environmental advocacy groups that underscore the necessity of regulating harmful substances. However, some manufacturers have expressed concerns regarding the implications of the notification requirements, fearing potential economic burdens and operational challenges. The discussion reflects a balance between promoting public health and addressing the operational realities faced by manufacturers of varying sizes.

Contention

Notable points of contention include the balance between regulatory oversight and business feasibility, particularly concerning small manufacturers. Additionally, the exemptions within the bill, such as those for federal regulations preempting state authority or for used products, have raised questions about the bill's effectiveness in thoroughly mitigating the risks posed by PFAS. Critics argue that these exemptions could undermine the intent of the legislation, while supporters maintain that they are necessary to avoid overreach and undue economic strain on small businesses.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.